Researchers working with induced pluripotent stem cells (iPSCs) gain an unprecedented understanding of human biology and disease. Experiments with iPSCs are especially illuminating in studies of the brain, where they provide scientists access to this intractable region so that they can model and develop therapies for psychiatric disorders, neurodegeneration, brain development, and infectious diseases.
In this virtual symposium brought to you by The Scientist, a panel of experts will present how they model a variety of neurological disorders with induced pluripotent stem cells (iPSCs) in 2D and 3D cell culture.
1:30 PM – Integrating patient-specific human iPSCs with CRISPR engineering to model genetic predisposition to psychiatric disorders Kristen Brennand, PhD
1:50 PM – Defining the temporal changes associated with frontotemporal dementia (FTD) with iPSC organoids Sally Temple, PhD
2:10 PM – Human iPSC-based disease modeling and therapeutic development Yanhong Shi, PhD
2:30 PM - Using human iPSCs to model the effects of in utero drug exposure on the developing brain Kimberly Christian, PhD
2:50 PM - Drug screens of human iPSC-derived neuronal networks on multi-electrode arrays Anne G. Bang, PhD
3:10 - 4:00 PM - Open panel Q&A session
Tuesday, May 25, 2021
1:00 - 4:00 PM, Eastern Time
Guo-li Ming, MD, PhD Perelman Professor, Neuroscience and Psychiatry University of Pennsylvania
Kristen Brennand, PhD Departments of Psychiatry and Genetics Yale University School of Medicine
Sally Temple, PhD Scientific Director Neural Stem Cell Institute, Albany NY
Yanhong Shi, PhD Herbert Horvitz Professor in Neuroscience Professor and Director, Division of Stem Cell Research Department of Developmental and Stem Cell Biology Beckman Research Institute of City of Hope
Kimberly Christian, PhD Research Assistant Professor, Neuroscience University of Pennsylvania
Anne G. Bang, PhD Director, Cell Biology Conrad Prebys Center for Chemical Genomics Sanford Burnham Prebys Medical Discovery Institute
TS_WEBINARSIGNUP_Harnessing Stem Cells to Model Neurological Disorders May 25, 2021
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com